Baseline Leptin/Adiponectin Ratio is a Significant Predictor of BMI Changes in Children/Adolescents after Intensive Lifestyle Intervention

Abstract

Introduction Abdominal obesity is a strong cardiometabolic risk factor that often occurs as early as in childhood. The negative effect of abdominal obesity on the metabolism is partially mediated by changes to the production of the major adipocyte hormones leptin and adiponectin. Leptin/adiponectin imbalance is associated with increased risk of developing obesity and type 2 diabetes mellitus.

Aim To determine whether leptin, adiponectin and the leptin/adiponectin ratio are significant predictors of body weight loss in intensively treated children/adolescents.

Methods 183 paediatric overweight or obese patients (71 boys and 112 girls), aged 7–16 years, were enrolled in a one-month intensive lifestyle intervention programme. Participants reduced their energy intake and engaged in a supervised exercise programme consisting of 5 physical activity units per day. The subjects were examined both before and after the intervention.

Results The mean BMI decrease achieved was−2.38±0.07 kg/m² (P<0.01). The decrease in plasma leptin concentration was−16.59±0.84 ng/mL (P<0.001) and CRP−0.38±0.04 mg/L (P<0.001). Changes in adiponectin concentrations were not statistically significant. The baseline leptin/adiponectin ratio was a significant predictor of decreases in body weight (P<0.005), BMI (P<0.0001) and waist circumference (P<0.05).

Conclusion The leptin/adiponectin ratio at baseline may be a useful predictor of results from interventions focused on decreasing BMIs in children/adolescents.

Key words

abdominal obesity - leptin - adiponectin - CRP - cardiovascular risk

• References

• 1 Gurnani M, Birken C, Hamilton J. Childhood obesity: Causes, consequences, and management. Pediatr Clin North Am 2015; 62: 821-840
• 2 Karnik S, Kanekar A. Childhood obesity: A global public health crisis. Int J Prev Med 2012; 3: 1-7
• 3 Kunešová M, Vignerová J, Pařízková J. et al. Long-term changes in prevalence of overweight and obesity in Czech 7-year-old children: Evaluation of different cut-off criteria of childhood obesity. Obes Rev 2011; 12: 483-491
• 4 Anderson PM, Butcher KE. Childhood obesity: Trends and potential causes. Future Child 2006; 16: 19-45
• 5 Hubacek JA. Eat less and exercise more – is it really enough to knock down the obesity pandemia?. Physiol Res 2009; 58 (Suppl. 01) S1-S6
• 6 Svačina S, Owen K. [Syndrom of insulin resistence]. Svačina S, Owen K. (eds.) In [Metabolic syndroma and lipids] [Article in Czech], Triton. 2003: 53-57
• 7 Polák J, Klimčáková E, Kováčiková M. et al. The endocrine function of adipose tissue in the pathogenesis of insulin resistence. [Article in Czech] Interní Med 2006; 8: 443-446
• 8 Muller G, Ertl J, Gerl M. et al. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272: 10585-10593
• 9 Seufert J, Kieffer TJ, Leech CA. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: Implications for the development of adipogenic diabetes mellitus. J Clin Endocrinol Metab 1999; 84: 670-676
• 10 Yadav A, Kataria MA, Saini V. et al. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 2013; 417: 80-84
• 11 DePaoli AM. 20 years of leptin: Leptin in common obesity and associated disorders of metabolism. J Endocrinol 2014; 223: T71-T81
• 12 Lin H, Hu M, Zan Y. et al. The effect of exercise on adiponectin and leptin levels in overweight or obese subjects: A meta-analysis of randomized controlled trials. Sport Sci Health 2017; 13: 303-314
• 13 Ostlund Jr RE, Yang JW, Klein S. et al. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996; 81: 3909-3913
• 14 Adamczak M, Wiecek A. The adipose tissue as an endocrine organ. Semin Nephrol. 2013; 33: 2-13
• 15 Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13: 84
• 16 Silha JV, Krsek M, Skrha JV. et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331-335
• 17 Rueda-Clausen CF, Lahera V, Calderón J. et al. The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors. Int J Cardiol 2010; 139: 32-41
• 18 Nguyen PA, Heggermont WA, Vanhaverbeke M. Leptin-adiponectin ratio in pre-diabetic patients undergoing percutaneous coronary intervention. Acta Cardiol 2015; 70: 640-646
• 19 Lim CC, Teo BW, Tai ES. et al. Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults. PloS One 2015; 10: e0122009
• 20 Lekva T, Michelsen AE, Aukrust P. et al. Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus. Cardiovasc Diabetol 2017; 16: 5
• 21 Kappelle PJ, Dullaart RP, van Beek AP. et al. The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: A prospective nested case-control study. Eur J Intern Med 2012; 23: 755-759
• 22 Dali-Youcef N, Mecili M, Ricci R. et al. Metabolic inflammation: Connecting obesity and insulin resistance. Ann Med 2013; 45: 242-253
• 23 Lau DC, Yan H, Dhillon B. Metabolic syndrome: A marker of patients at high cardiovascular risk. Can J Cardiol 2006; 22 Suppl B 85B-90B
• 24 Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 2013; 14: 232-244
• 25 Dolinsky DH, Armstrong SC, Kinra S. The clinical treatment of childhood obesity. Indian J Pediatr 2013; 80 (Suppl. 01) S48-S54
• 26 Motyková E, Zlatohlávek L, Prusiková M. et al. Lifestyle modification induced weight loss and changes of cardiometabolic risk factors including lowering of inflammatory response in obese children. Neuro Endocrinol Lett 2011; 32 (Suppl. 02) 55-59
• 27 Zlatohlávek L, Hubáček JA, Vrablík M. et al. The impact of physical activity and dietary measures on the biochemical and anthropometric parameters in obese children. Is there any genetic predisposition?. Cent Eur J Public Health 2015; 23 (Suppl): S62-S66
• 28 Zlatohlavek L, Vrablik M, Motykova E. et al. FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention. Clin Biochem 2013; 46: 313-316
• 29 Zlatohlavek L, Maratka V, Tumova E. et al. Body adiposity changes after life style interventions in children/adolescents and the NYD-SP18 and TMEM18 variants. Med Sci Monit 2018; 24: 7493-7498
• 30 Kwiterovich PO. Plasma lipid and lipoprotein levels in childhood. Ann NY Acad Sci 1991; 623: 90-107
• 31 Canas JA, Sweeten S, Balagobal PB. Biomarkers for cardiovascular risk in children. Curr Opion Cardiol 2013; 28: 103-114
• 32 Weber KS, Spörkel O, Mertens M. et al. Positive effects of promoting physical activity and balanced diets in a primary school setting with a high proportion of migrant school children. Exp Clin Endocrinol Diabetes 2017; 125: 554-562
• 33 Bouchard C, Tremblay A, Després JP. et al. The response to long-term overfeeding in identical twins. N Engl J Med 1990; 322: 1477-1482
• 34 Vrablík M, Dobiášová M, Zlatohlávek L. et al. Biomarkers of cardiometabolic risk in obese/overweight children: Effect of lifestyle intervention. Physiol Res 2014; 63: 745-752
• 35 Kitsios GD, Kent DM. Personalised medicine: Not just in our genes. BMJ 2012; 344: e2161
• 36 Parkes M. Personalised medicine and genetic prediction – are we there yet?. Clin Med (Lond) 2013; 13 (Suppl. 06) s62-s64
• 37 Visvikis-Siest S, Aldasoro Arguinano AA, Stathopoulou M. et al. 8^th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016. Drug Metab Pers Ther 2017; 32: 119-127
• 38 Wozniak SE, Gee LL, Wachtel MS. et al. Adipose tissue: The new endocrine organ?. A review article. Dig Dis Sci 2009; 54: 1847-1856
• 39 Škop V, Kontrová K, Zídková J. et al. Adipocytokins – recently discovered hormones of the adipose tissue. Chem Listy 2009; 103: 187-192
• 40 McGown C, Birerdinc A, Younossi ZM. Adipose tissue as an endocrine organ. Clin Liver Dis 2014; 18: 41-58
• 41 Farr OM, Gavrieli A, Mantzoros CS. Leptin applications in 2015: What have we learned about leptin and obesity?. Curr Opin Endocrinol Diabetes Obes 2015; 22: 353-359
• 42 Nigro E, Scudiero O, Monaco ML. et al. New insights into adiponectin role in obesity and obesity-related diseases. Biomed Res Int 2014; 2014: 658913
• 43 López-Jaramillo P, Gómez-Arbeláez D, López-López J. et al. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm Mol Biol Clin Invest 2014; 18: 37-45
• 44 Donoso MA, Muñoz-Calvo MT, Barrios V. et al. Increased leptin/adiponectin ratio and free leptin index are markers of insulin resistance in obese girls during pubertal development. Horm Res Paediatr 2013; 80: 363-370
• 45 Stakos DA, Papaioannou HI, Angelidou I. et al. Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children. J Pediatr Endocrinol Metab 2014; 27: 221-228
• 46 Li G, Xu L, Zhao Y. et al. Leptin-adiponectin imbalance as a marker of metabolic syndrome among Chinese children and adolescents: The BCAMS study. PLoS One 2017; 12: e0186222
• 47 Suchanek P, Kralova-Lesna I, Poledne R. et al. An AHSG gene variant modulates basal metabolic rate and body composition development after a short-time lifestyle intervention. Neuro Endocrinol Lett 2011; 32 (Suppl. 02) 32-36
• 48 Suchanek P, lanska V, Hubacek JA. Body composition changes in adult females after lifestyle intervention are influenced by the NYD-SP18 variant. Cent Eur J Public Health 2015; 23 (Suppl: ): S19-S22